$15.31
Icosavax is a biotechnology business based in the US. Icosavax shares (ICVX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.00 – the same closing value as a week prior. Icosavax employs 60 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Icosavax stock
- Earn 4.5% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Unlimited bonus amounts Oct 16-27
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Icosavax stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ICVX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Icosavax stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Icosavax stock price (NASDAQ: ICVX)
Use our graph to track the performance of ICVX stocks over time.Icosavax shares at a glance
Latest market close | $0.00 |
---|---|
52-week range | $5.88 - $16.11 |
50-day moving average | $15.46 |
200-day moving average | $10.53 |
Wall St. target price | $18.50 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-2.20 |
Is it a good time to buy Icosavax stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Icosavax price performance over time
Historical closes compared with the close of $0 from 2024-03-22
1 week (2024-10-05) | N/A |
---|---|
1 month (2024-09-12) | N/A |
3 months (2024-07-12) | N/A |
6 months (2024-04-12) | N/A |
1 year (2023-10-16) | -100.00% |
---|---|
2 years (2022-10-14) | -100.00% |
3 years (2021-10-15) | 25.26 |
5 years (2019-10-12) | N/A |
Icosavax financials
Gross profit TTM | $-30,974,000 |
---|---|
Return on assets TTM | -26.73% |
Return on equity TTM | -42.23% |
Profit margin | 0% |
Book value | $4.64 |
Market Capitalization | $769 million |
TTM: trailing 12 months
Icosavax share price volatility
Over the last 12 months, Icosavax's shares have ranged in value from as little as $5.88 up to $16.105. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Icosavax's is 1.278. This would suggest that Icosavax's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Icosavax's beta into context you can compare it against those of similar companies.
Icosavax overview
Icosavax, Inc. , a biopharmaceutical company, develops vaccines against infectious diseases through virus-like particle (VLP) platform technology. Its lead product candidate IVX-A12, a respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine. The company also develops IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; and IVX-241, a vaccine candidate with hMPV target. Icosavax, Inc. was incorporated in 2017 and is headquartered in Seattle, Washington. As of February 19, 2024, Icosavax, Inc.
Frequently asked questions
nullWhat percentage of Icosavax is owned by insiders or institutions?
Currently 3.472% of Icosavax shares are held by insiders and 87.635% by institutions. How many people work for Icosavax?
Latest data suggests 60 work at Icosavax. When does the fiscal year end for Icosavax?
Icosavax's fiscal year ends in December. Where is Icosavax based?
Icosavax's address is: 1930 Boren Avenue, Seattle, WA, United States, 98101 What is Icosavax's ISIN number?
Icosavax's international securities identification number is: US45114M1099
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
9 Best Discount Brokers of 2024 for Low-Cost Trading
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question